EVT 

$0
11
+$0+0% Monday 00:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Mar 26
$0.13
Sep 25
$0.15
Mar 25
$0.1
Sep 24
$0.13
Mar 24
$0.09
10Y Growth
-2.4%
5Y Growth
N/A
3Y Growth
5.57%
1Y Growth
5.26%

Earnings

22FebExpected
Q4 2022
Q2 2023
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
-0.08
0.03
0.14
0.25
Expected EPS
0.2530490204159269
Actual EPS
0.2342773846760785

Financials

2.76%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
1.55BRevenue
42.71MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EVHEF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that competes with EVT in the pharmaceutical and biotech sectors, particularly in drug discovery and development.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a large pharmaceutical company that competes with EVT in developing and commercializing drugs for various therapeutic areas.
Merck
MRK
Mkt Cap214.76B
Merck is a leading pharmaceutical company that competes with EVT in the research, development, and manufacturing of pharmaceuticals.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline is a global healthcare company that competes with EVT in the pharmaceutical and vaccine markets.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson is a diversified healthcare company that competes with EVT across several segments, including pharmaceuticals.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie is a biopharmaceutical company that competes with EVT in developing advanced therapies for complex diseases.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biotechnology company that competes with EVT in the discovery, development, and delivery of innovative medicines.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is a global biopharmaceutical company that competes with EVT in developing novel medicines for various diseases.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG is a healthcare company that competes with EVT in pharmaceuticals and diagnostics, focusing on oncology, immunology, and infectious diseases.
Sanofi
SNY
Mkt Cap124.45B
Sanofi is a global healthcare leader that competes with EVT in providing therapeutic solutions in a wide range of medical fields.

About

EVT Limited engages in the entertainment business in Australia, New Zealand, Singapore, and Germany. The company operates through Entertainment, Entertainment Germany, Hotels and Resorts, Thredbo Alpine Resort, and Property and Other Investments segments. It is involved in the cinema and outdoor cinema operations under the Event Cinemas, BCC Cinemas, Rialto Cinemas, Embassy Theatre, CineStar, Moonlight Cinema, and Skyline Drive In names; operation of spas and golf courses under the SpaQ, Ubika Spa, Thredbo, and Rydges names; and bar, restaurant, and theatre operations. The company also owns, operates, and manages hotels and resorts under the QT, Rydges, Atura, LyLo, and Thredbo Alpine names. In addition, it engages in the property investment and development activities; property rental activities; and hotel management, and media and entertainment technology businesses. The company was formerly known as Event Hospitality & Entertainment Limited and changed its name to EVT Limited in October 2022. The company was founded in 1910 and is headquartered in Sydney, Australia.
Show more...
CEO
Country
AU
ISIN
AU000000EVT1

Listings

0 Comments

Share your thoughts

FAQ

What is EVT stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange EVT stocks are traded under the ticker EVHEF.
When is the next EVT earnings date?
EVT is going to release the next earnings report on August 31, 2026.
What were EVT earnings last quarter?
EVHEF earnings for the last quarter are 0.17 USD per share, whereas the estimation was 0.18 USD resulting in a -7.42% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is EVT revenue for the last year?
EVT revenue for the last year amounts to 1.55B USD.
What is EVT net income for the last year?
EVHEF net income for the last year is 42.71M USD.
Does EVT pay dividends?
Yes, EVHEF dividends are paid semi-annual. The last dividend per share was 0.13 USD. As of today, Dividend Yield (FWD)% is 0%.
When did EVT complete a stock split?
EVT has not had any recent stock splits.